Keyword Connections

tyrosine kinase inhibitors

Journals

9

1 Bioorganic chemistry

2 Scientific reports

3 PloS one

4 British journal of clinical pharmacology

5 Cureus

6 journal of clinical oncology : official journal of the american society of clinical oncology

7 Journal of hospital medicine

8 Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

9 Annals of hematology

Research Groups

0

No Research Group Connected

Bibliographies

28

1 Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis.

2 Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios.

3 Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

4 Nitrification inhibitors can increase post-harvest nitrous oxide emissions in an intensive vegetable production system.

5 checkpoint molecule pd-1-assisted cd8+ t lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

6 tyrosine kinase inhibitors in egfr-mutated large-cell neuroendocrine carcinoma of the lung a case report

7 long-term disease control in advanced renal cell cancer with brain metastases with pazopanib (case report and literature review)

8 efficacy of vandetanib in treating locally advanced or metastatic medullary thyroid carcinoma according to recist criteria: a systematic review and meta-analysis

9 mechanistic systems modeling to improve understanding and prediction of cardiotoxicity caused by targeted cancer therapeutics

10 Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study.

11 A systematic review of medicinal plants used against Echinococcus granulosus.

12 the infection of cucumber (cucumis sativus l.) roots by meloidogyne incognita alters the expression of actin-depolymerizing factor (adf) genes, particularly in association with giant cell formation

13 a combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer

14 tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in cml patients

15 Discovery of 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)-N,N-diethylpiperidine-1-carboxamide as kinase inhibitor for the treatment of colorectal cancer.

16 Haematological adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukaemia: A network meta-analysis.

17 RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice

18 can pharmacological receptor tyrosine kinase inhibitors sensitize poor outcome breast tumors to immune-based therapies?

19 chemotherapy and egfr tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients

20 importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance

21 Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2

22 severe adverse effects associated with tyrosine kinase inhibitors therapy in chronic myeloid leukaemia – case reports and literature review

23 increased risk of severe infections in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis

24 alignment independent 3d-qsar, quantum calculations and molecular docking of mer specific tyrosine kinase inhibitors as anticancer drugs

25 tyrosine kinase inhibitors and pregnancy

26 outcomes of research biopsies in clinical trials of egfr mutation-positive non-small cell lung cancer patients pretreated with egfr-tyrosine kinase inhibitors

27 Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors.

28 EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.